International Assets Investment Management LLC Purchases Shares of 15,860 Exscientia plc (NASDAQ:EXAI)

International Assets Investment Management LLC purchased a new position in shares of Exscientia plc (NASDAQ:EXAI) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 15,860 shares of the company’s stock, valued at approximately $77,000.

A number of other large investors also recently modified their holdings of the company. Vanguard Personalized Indexing Management LLC purchased a new position in Exscientia in the second quarter valued at approximately $54,000. Federated Hermes Inc. purchased a new position in shares of Exscientia in the 2nd quarter valued at $115,000. EntryPoint Capital LLC lifted its holdings in shares of Exscientia by 22.8% during the 1st quarter. EntryPoint Capital LLC now owns 31,171 shares of the company’s stock valued at $178,000 after acquiring an additional 5,784 shares in the last quarter. Susquehanna Fundamental Investments LLC purchased a new stake in Exscientia during the 2nd quarter worth $256,000. Finally, Bank of New York Mellon Corp increased its holdings in Exscientia by 108.8% in the 2nd quarter. Bank of New York Mellon Corp now owns 388,459 shares of the company’s stock valued at $1,981,000 after purchasing an additional 202,377 shares in the last quarter. 41.58% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently commented on EXAI. Barclays reissued an “equal weight” rating and set a $5.00 price target on shares of Exscientia in a research report on Tuesday, August 13th. TD Cowen restated a “hold” rating on shares of Exscientia in a research note on Friday, August 9th.

Exscientia Price Performance

NASDAQ EXAI opened at $5.28 on Friday. The company has a 50-day moving average price of $5.00 and a two-hundred day moving average price of $5.10. The stock has a market cap of $638.30 million, a price-to-earnings ratio of -4.06 and a beta of 0.83. The company has a current ratio of 5.93, a quick ratio of 5.93 and a debt-to-equity ratio of 0.06. Exscientia plc has a 52 week low of $3.80 and a 52 week high of $7.91.

Exscientia (NASDAQ:EXAI) last posted its quarterly earnings data on Thursday, August 15th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.31) by ($0.05). Exscientia had a negative net margin of 620.99% and a negative return on equity of 37.56%. The company had revenue of $5.60 million during the quarter. Analysts forecast that Exscientia plc will post -1.25 EPS for the current year.

Exscientia Company Profile

Exscientia plc, an artificial intelligence (AI) driven Pharma-tech company, engages in design and develop differentiated medicines for diseases with high unmet patient needs. The company's lead product candidate GTAEXS617, a CDK7 inhibitor, which is currently in a Phase 1/2 trial to manage the potential toxicities associated with CDK7 as well as optimizing pharmacokinetics for maximizing on-target efficacy.